Belrestotug
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Belrestotug, covering 2025-09-10 to 2025-09-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC) [Phase 3]